Allergan Says Proposed Class Rep Is 'Serial Litigant'
Pharmaceutical company Allergan on Tuesday told a New York federal judge not to certify a proposed class of its investors in a stock drop suit it faces, calling the lead plaintiff...To view the full article, register now.
Already a subscriber? Click here to view full article